Limited Ability of the Proton-Pump Inhibitor Test to Identify Patients With Gastroesophageal Reflux Disease
Authors:
- Peter BytzerPBPeter Bytzer
- Roger JonesRJRoger Jones
- Nimish VakilNVNimish Vakil
- Ola JunghardOJOla Junghard
- Tore LindTLTore Lind
- Börje WernerssonBWBörje Wernersson
- John DentJDJohn Dent
- 1 December 2012
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 10 (12) , 1360-1366
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond StudyGut, 2010
- American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux DiseaseGastroenterology, 2008
- New algorithm for the treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2007
- Diagnostic value of the proton pump inhibitor test for gastro‐oesophageal reflux disease in primary careAlimentary Pharmacology & Therapeutics, 2006
- Review article: how valuable are proton‐pump inhibitors in establishing a diagnosis of gastro‐oesophageal reflux disease?Alimentary Pharmacology & Therapeutics, 2005
- Endoscopy‐negative reflux disease: what is the value of a proton‐pump inhibitor test in everyday clinical practice?Scandinavian Journal of Gastroenterology, 2003
- The omeprazole test is as sensitive as 24‐h oesophageal pH monitoring in diagnosing gastro‐oesophageal reflux disease in symptomatic patients with erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2000
- Evaluation of omeprazole as a cost‐effective diagnostic test for gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- One-Week Omeprazole Treatment in the Diagnosis of Gastro-oesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1998
- Omeprazole 10 Milligrams Once Daily, Omeprazole 20 Milligrams Once Daily, or Ranitidine 150 Milligrams Twice Daily, Evaluated as Initial Therapy for the Relief of Symptoms of Gastro-oesophageal Reflux Disease in General PracticeScandinavian Journal of Gastroenterology, 1997